Stocklytics Platform
Asset logo for symbol FOLD
Amicus Therapeutics
FOLD70
$9.21arrow_drop_down0.21%-$0.01
Asset logo for symbol FOLD
FOLD70

$9.21

arrow_drop_down0.21%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Amicus Therapeutics (FOLD) Stocklytics Forecast

Amicus Therapeutics Inc (FOLD) is a biotechnology company that focuses on discovering, developing, and delivering innovative therapies for rare genetic diseases. The company's stock price, FOLD, has attracted attention from investors and analysts alike. What does the future hold for Amicus Therapeutics Inc and its stock?
When it comes to predicting the stock price of Amicus Therapeutics Inc (FOLD), there are various factors to consider. One approach is to analyze historical price patterns and trends. However, it's important to note that past performance does not guarantee future results. Another method is to utilize advanced technologies such as artificial intelligence (AI) and machine learning (ML) algorithms to forecast future stock prices.
add Amicus Therapeutics to watchlist

Keep an eye on Amicus Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Amicus Therapeutics (FOLD) stock?

Analysts have set a target price of $15.86 for Amicus Therapeutics (FOLD), based on forecasts from 22 analysts. The predicted price range extends from a high of $22 to a low of $11. This represents a potential increase of up to 138.87% and a decrease of 19.44% from the current price of $9.21. These forecasts are as of 2021 Mar 02.
help

What are the analyst ratings for Amicus Therapeutics (FOLD) stock?

The analyst ratings for Amicus Therapeutics (FOLD) are distributed as follows: 10 analysts recommend buying, 3 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 13 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Amicus Therapeutics .
help

What is the AI price prediction for Amicus Therapeutics (FOLD) stock?

At present, there is no AI or machine-learning-based price prediction available for Amicus Therapeutics (FOLD) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level